During the past decade, Charité Universitaetsmedizin Berlin - Campus Charité Mitte conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 23 clinical trials were completed, i.e. on average, 60.5% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 11 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte" #1 sponsor was "Pfizer" with 7 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Charite University, Berlin, Germany" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 5 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator and "Karl and Veronica Carstens Foundation" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte" are "Lymphoma" (6 trials), "Ulcerative Colitis" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Crohn's Disease" (4 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte" in a lesser frequency.

Most popular intervention types in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte" are "Drug" (63 trials), "Biological" (12 trials), "Device" (9 trials), "Other" (9 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "radiation therapy" (7 trials), "cyclophosphamide" (5 trials), "filgrastim" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte" are 81 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Charité Universitaetsmedizin Berlin - Campus Charité Mitte". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Charité Universitaetsmedizin Berlin - Campus Charité Mitte, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Charité Universitaetsmedizin Berlin - Campus Charité Mitte, 5 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".